《更新》EMA／DARWIN EU関係の更新（2026年3月4日付）

※初出掲載 （2026.03.05）
※追記更新 （2026.03.09）

3/4付でEMAから「DARWIN EU関係」についての更新と新規発出がなされています。

DARWIN EUとは、リアルワールドデータのデータ分析およびのネットワークです。

ちなみに、新規発出文書は品目ごとの研究内容です。

関係者および興味のある方は、下記URLsの更新と新規発出をご参照ください。

• 更新ウェブサイト「Data Analysis and Real World Interrogation Network (DARWIN EU)」
  https://www.ema.europa.eu/en/about-us/how-we-work/data-regulation-big-data-other-sources/real-world-evidence/data-analysis-real-world-interrogation-network-darwin-eu
• 更新「DARWIN EU Advisory Board: Membership」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-advisory-board-membership_en.pdf
• 更新「DARWIN EU data partners onboarded in phases I, II and III」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-data-partners-onboarded-phases-i-ii-iii_en.pdf
• 更新「Darwin EU: Making health data count」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-making-health-data-count_en.pdf
• 新規「Darwin EU study: Co-prescribing medicines in pulmonary arterial hypertension」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-study-co-prescribing-medicines-pulmonary-arterial-hypertension_en.pdf
• 新規「Darwin EU study: How medicines are used to treat adults and children with lupus」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-study-how-medicines-are-used-treat-adults-children-lupus_en.pdf
• 新規「Darwin EU study: Clozapine and the incidence of severe neutropenia over time」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-study-clozapine-incidence-severe-neutropenia-over-time_en.pdf
• 新規「Darwin EU study: Overall survival in patients with non-small cell lung cancer treated with selected immunotherapies」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-study-overall-survival-patients-non-small-cell-lung-cancer-treated-selected-immunotherapies_en.pdf
• 新規「Darwin EU study: Treatment patterns and user characteristics for novel migraine medicines」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-study-treatment-patterns-user-characteristics-novel-migraine-medicines_en.pdf
• 新規「Darwin EU study: Is there a link between blood clots and common painkillers in women who use hormonal birth control」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-study-there-link-between-blood-clots-common-painkillers-women-who-use-hormonal-birth-control_en.pdf
• 新規「Darwin EU: Is there a risk of suicidality after taking the antibiotic doxycycline」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-there-risk-suicidality-after-taking-antibiotic-doxycycline_en.pdf
• 新規「Darwin EU: How often respiratory syncytial virus (RSV) affects different age groups in Europe」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-how-often-respiratory-syncytial-virus-rsv-affects-different-age-groups-europe_en.pdf
• 新規「Darwin EU study: Use of higher-risk antibiotics from the WHO Watch list, including azithromycin」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-study-use-higher-risk-antibiotics-who-watch-list-including-azithromycin_en.pdf
• 新規「Darwin EU study: Background incidence rates of selected vaccine adverse events of special in Europe」
  https://www.ema.europa.eu/en/documents/other/darwin-eu-study-background-incidence-rates-selected-vaccine-adverse-events-special-europe_en.pdf

【3/9付追記更新】
3/6付でEMAから「Darwin EU: Making health data count」が更新されています。

興味のある方は、下記URLの更新文書をご参照ください。
https://www.ema.europa.eu/en/documents/other/darwin-eu-making-health-data-count_en.pdf